Literature DB >> 2991627

Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan.

K Tajima, T Kuroishi.   

Abstract

From the mortality statistics on malignant lymphomas in Japan and nationwide studies on T- and B-cell malignancies, the number of deaths from adult T-cell leukemia/lymphoma (ATL) in adults older than 20 years in the Kyushu district was estimated at 339 or more per year in 1978-82. The incidence for ATL per 100,000 was estimated at 3.5 for adults and 5.7 for persons over 40 years of age in the Kyushu district. From the information from a nationwide study on the distribution of ATL virus (ATLV) carriers among volunteer blood donors, the number of ATLV-carriers in adults older than 20 years in Kyushu was calculated at 561,000 (310,000-793,000 at 95% confidence limit) in recent years. The incidence of ATL per 1,000 ATLV carriers in Kyushu was calculated at 0.60 (0.43-1.09) for adults, and 0.75 (0.55-1.18) for those over 40 years of age which was very close to the independently calculated figure of 0.84 (0.75-0.95) in the Goto Islands (the most typical ATL-endemic area). From these results, it was suggested that one case of ATL developed per year among 1,700 (900-2,300) ATLV-carrier adults and among 1,300 (800-1,800) ATLV carriers older than 40 years in Kyushu in recent years.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991627

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  26 in total

1.  HTLV-I infection in French West Indies: a case-control study.

Authors:  N Frery; M Chavance; I Valette; L Schaffar; C Neisson-Vernant; J Jouannelle; N Monplaisir
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

2.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

3.  Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter.

Authors:  Kasey L Konesky; Jennifer K Nyborg; Paul J Laybourn
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  Follow-up of asymptomatic HTLV-I carriers among blood donors in Kyushu, Japan.

Authors:  S Tokudome; Y Maeda; K Fukada; D Teshima; T Asakura; E Sueoka; Y Motomura; Y Kusumoto; Y Imamura; T Kiyokawa
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

5.  Anti HTLV-I antibodies and HLA phenotypes in the West Indies.

Authors:  M Chavance; N Monplaisir; I Valette; L Schaffar-Deshayes; C Raffoux
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

6.  Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line.

Authors:  M Hijikata; N Kato; T Sato; Y Kagami; K Shimotohno
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 7.  Peripheral T-cell lymphoma.

Authors:  S Watanabe; K Mukai; M Shimoyama
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

Review 8.  Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).

Authors:  K Tajima
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

Review 9.  Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.

Authors:  T Suchi; K Lennert; L Y Tu; M Kikuchi; E Sato; A G Stansfeld; A C Feller
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

Review 10.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.